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Abstract
Chromatographic evidence supporting the similarity of the yellow chromophores isolated from aged human and
brunescent cataract lenses and calf lens proteins ascorbylated in vitro is presented. The water-insoluble fraction from early
stage brunescent cataract lenses was solubilized by sonication (WISS) and digested with a battery of proteolytic enzymes
under argon to prevent oxidation. Also, calf lens proteins were incubated with ascorbic acid for 4 weeks in air and submitted
to the same digestion. The percent hydrolysis of the proteins to amino acids was approximately 90% in every case. The
content of yellow chromophores was 90, 130 and 250 A330 units/g protein for normal human WISS, cataract WISS and
ascorbate-modified bovine lens proteins respectively. Aliquots equivalent to 2.0 g of digested protein were subjected to size-
exclusion chromatography on a Bio-Gel P-2 column. Six peaks were obtained for both preparations and pooled. Side by side
thin-layer chromatography (TLC) of each peak showed very similar Rf values for the long wavelength-absorbing
fluorophores. Glycation with [U-14C]ascorbic acid, followed by digestion and Bio-Gel P-2 chromatography, showed that the
incorporated radioactivity co-eluted with the A330-absorbing peaks, and that most of the fluorescent bands were labeled after
TLC. Peaks 2 and 3 from the P-2 were further fractionated by preparative Prodigy C-18 reversed-phase high-performance
liquid chromatography. Two major A330-absorbing peaks were seen in peak 2 isolated from human cataract lenses and
5 peaks in fraction 3, all of which eluted at the same retention times as those from ascorbic acid glycated calf lens proteins.
HPLC fractionation of P-2 peaks 4, 5 and 6 showed many A330-absorbing peaks from the cataract WISS, only some of which
were identical to the asorbylated proteins. The major fluorophores, however, were present in both preparations. These data
provide new evidence to support the hypothesis that the yellow chromophores in brunescent lenses represent advanced
glycation endproducts (AGEs) probably due to ascorbic acid glycation in vivo. ß 2001 Elsevier Science B.V. All rights
reserved.
Keywords: Human lens; Brunescent cataract; Ascorbic acid; Advanced glycation endproduct; Maillard reaction; Yellow chromophore;
Fluorescence; Aging
0925-4439 / 01 / $ ^ see front matter ß 2001 Elsevier Science B.V. All rights reserved.
PII: S 0 9 2 5 - 4 4 3 9 ( 0 1 ) 0 0 0 5 1 - 5
Abbreviations: AGE, advanced glycation endproduct; DTPA, diethylenetriaminepentaacetic acid; HFBA, hepta£uorobutyric acid;
HPLC, high-performance liquid chromatography; TLC, thin-layer chromatography; WI, water-insoluble fraction; WISS, water-insoluble
sonicate supernatant; WS, water soluble fraction
* Corresponding author. Fax: +1-573-884-4868. E-mail address: ortwerthb@health.missouri.edu (B.J. Ortwerth).
BBADIS 62039 13-7-01
Biochimica et Biophysica Acta 1537 (2001) 14^26
www.bba-direct.com
1. Introduction
The aging of the human lens is characterized by an
increase in water-insoluble (WI) proteins associated
with high levels of yellow chromophores and non-
tryptophan £uorescence [1^4]. These biochemical
changes are all enhanced in senile and brunescent
cataractous lenses. The glycation of lens proteins
has been suggested to be one of the major protein
modi¢cations present in older lenses, and indeed di-
abetic patients are at higher risk for cataract forma-
tion [5]. Due to the possibly life-long stability of the
lens crystallins, they can accumulate damaging mod-
i¢cations continuously. In time, these modi¢cations
may be responsible for the protein aggregation, pro-
tein crosslinking seen in age-onset cataract [6^8]. A
dramatic, visible increase in protein-bound chromo-
phores occurs during brunescent cataract formation
especially in tropical countries [9,10].
Ascorbic acid is present in the human lens in rel-
atively large amounts (up to 2 mM), which is higher
than the normal glucose levels [11,12]. This is poten-
tially signi¢cant, because ascorbic acid has been
shown to participate in both glycation reactions
[13] and the metal-dependent generation of oxygen
free radicals in vitro [14]. In vitro incubation experi-
ments have revealed that the oxidation products of
ascorbic acid can rapidly react with lens proteins via
a glycation mechanism and to form cross-linked pro-
teins with characteristic browning and £uorescence
[15,16]. These changes resemble those occurring in
the lens during normal aging and cataract formation.
The structures of several advanced glycation end-
products (AGEs), such as pentosidine [17,18], car-
boxymethyllysine [19] and LM-1 (vesperlysine A)
[20,21] are known, and have been identi¢ed in hu-
man lens proteins. Similar compounds can be formed
by the reaction of lens proteins with ascorbic acid in
vitro, however, the exact glycating agent responsible
for forming these AGEs in vivo still remains largely
unknown.
In order to prove a role for ascorbate glycation in
lens aging and cataract formation, it will be neces-
sary to isolate the AGEs from ascorbylated proteins,
and show that several of these are identical to the
yellow, £uorescent compounds isolated from both
aged human and brunescent cataract lenses. The
identity of the major yellow chromophores bound
to human lens proteins has been pursued by many
investigators, but with little success. Several puri¢ed
compounds have been isolated from human cataract,
but these have largely been tryptophan oxidation
products [22,23] or ¢lter compounds such as 3-hy-
droxykynurenine glycoside, which form adducts
with proteins during aging [24]. While the presence
of AGEs has been demonstrated in human lenses, the
quantities, when measured, were very low. Therefore,
the major adducts have not as yet been isolated or
identi¢ed. In this report we describe the extensive
enzymatic digestion of human cataract lens WI pro-
teins, and the chromatographic pro¢les of these di-
gests by size exclusion Bio-Gel chromatography. The
components of the various peaks were then com-
pared by reversed-phase high-performance liquid
chromatography (RP-HPLC) in order determine the
complexity of this population and to show the sim-
ilarity of the yellow chromophores in human cataract
lens with those produced by ascorbic acid glycation
in vitro. It is also anticipated that these procedures
may provide the basis of a reproducible procedure to
isolate the yellow chromophores present in aged hu-
man lenses and cataracts for further study.
2. Materials and methods
2.1. Materials
Ascorbic acid (99.6% pure) was obtained from
Fisher Chemical Co. (St. Louis, MO). All other re-
agents were obtained in the highest purity available
from Sigma Chemical Co. (St. Louis, MO). L-
[U-14C]ascorbic acid was prepared from D-
[U-14C]glucose by the method reviewed by Crawford
and Crawford [25] as described in detail previously
[26]. This labeled ascorbic acid was synthesized in
crystalline form by Valeri V. Mossine at this univer-
sity. De-ionized water (18 M6 resistance or greater)
was used for all experiments. Phosphate bu¡ers were
treated with 10 g/l Chelex resin (200^400 mesh, Bio-
Rad Laboratories, Richmond, CA) to remove trace
metal ion contaminants as described by Beyer and
Fridovitch [27], and ¢ltered through a 0.2-Wm nitro-
cellulose ¢lter before use.
Aged normal human lenses were obtained as a
kind gift from the Heartland Lions Eye Tissue
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Bank following cornea removal. Brunescent cataracts
were collected from hospitals in Rajkot, India and
stored frozen at the Patney Eye Clinic. After trans-
port by hand to Columbia, MO, they were stored
individually frozen at 370‡C until use.
2.2. Preparation of lens proteins
Newborn calf lenses (1.0^1.2 g) were obtained
from Pel-Freeze Biologicals, Rogers, AR, shipped
in dry ice and stored at 370‡C. The water-soluble
(WS) fraction was prepared from the outer cortex of
thawed, decapsulated lenses by removing the outer
1.0 cm of tissue with a cork borer. This tissue was
homogenized in deionized water with a hand Dounce
homogenizer and the resulting homogenate was cen-
trifuged at 27 000Ug for 20 min. The supernatant
was dialyzed extensively against water and used di-
rectly for glycation experiments. The protein content
of these calf lens protein preparations was deter-
mined using the BCA assay as described by the man-
ufacturer (Pierce, Rockford, IL).
Type I and II brunescent lenses (dark yellow to tan
in color) were decapsulated, pooled and homoge-
nized in deionized water. The 27 000Ug pellet was
obtained and washed three times with an equal vol-
ume of deionized water. The ¢nal pellet was resus-
pended once again and sonicated in ice for 5 min at a
power setting of 4 and a duty cycle of 40%. The
solubilized protein was recovered after centrifugation
at 27 000Ug, and the pellet was resuspended and
sonicated again. The second supernatant, when com-
bined with the ¢rst, represented 95% of the total
water-insoluble (WI) fraction and was designated
the WI sonicate supernatant (WISS) as described
previously [28,29].
2.3. Glycation reactions
Dialyzed calf lens cortical proteins (10 mg/ml)
were incubated with 20 mM L-ascorbic acid in 0.1
M Chelex-treated phosphate bu¡er (pH 7.0) contain-
ing 1.0 mM DTPA. Each reaction mixture was ster-
ile-¢ltered through a 0.22-Wm nylon syringe ¢lter into
a sterile plastic culture £ask. Each £ask was wrapped
in aluminum foil and incubated in the dark at 37‡C
for 4 weeks. The reaction mixtures were then dia-
lyzed extensively against 5 mM Chelex-treated phos-
phate bu¡er, pH 7.0 at a ratio of 1 to 8 (v/v) for
several changes.
2.4. Proteolytic digestion of ascorbylated calf lens
proteins and cataract lens proteins
Proteolytic digestion was carried out by a modi¢-
cation of the method of Luthra et al. [23]. Solutions
containing 10 mg/ml of either pooled cataract WISS
fractions or dialyzed 4-week ascorbylated lens pro-
teins were prepared in 5.0 mM Chelex treated phos-
phate bu¡er (pH 7.0), and 3.6 mg of porcine intesti-
nal peptidase (Sigma P7500) was added per 100 mg
protein. The digestion mixture was then sterile ¢l-
tered into a sterile tissue culture £ask, bubbled with
argon, and incubated for 24 h at 37‡C in the dark. A
solution of Pronase (Sigma P5147) was then added
through a syringe ¢lter after 24 h to a level of 3.6 mg
Pronase, and digestion was continued for 72 h with
two more additions of Pronase after 24 and 48 h,
respectively. Following adjustment of the digest to
pH 8.5 with 1.0 M NaOH, leucine aminopeptidase
(Sigma L 5658) was added to a ¢nal concentration of
40 units per 100 mg protein. The digest was sterile
¢ltered, bubbled with argon and incubated for 24 h
at 37‡C. After adjusting the pH of the digest to 7.6
with 1.0 M HCl, it was sterile ¢ltered again, bubbled
with argon, and further proteolysis carried out by the
sequential sterile addition of 5.0 mg of trypsin per
100 mg protein (Sigma T8642), 5.0 mg chymotrypsin
(Sigma C4149) and ¢nally 3.6 mg Proteinase K (Sig-
ma P6556) per 100 mg protein with 24 h between
each addition. Corresponding enzyme blanks incu-
bated without added protein were also incubated
and analyzed on several occasions. Amino acid anal-
ysis was used to evaluate the e⁄ciency of the enzyme
digestion by comparing the total free amino acids in
a 12% sulfosalicylic acid supernatant to that of an
equivalent aliquot acid hydrolyzed in 6.0 N HCl, for
20 h.
2.5. Bio-Gel P-2 size exclusion chromatography
Digests from either cataract WISS or ascorbylated
proteins were concentrated and subjected to gel ¢l-
tration chromatography on a Bio-Gel P-2 column
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(5U76 cm, bed volume 1.5 l), with 25 mM formic
acid as eluant. Samples equivalent to 2 g of digested
protein (40 ml) were applied to the column and 14.5-
ml fractions were collected at a £ow rate of 1 ml/min.
The collected fractions were monitored for absor-
bance at 330 nm, for £uorescence at excitation/emis-
sion = 350/450 nm, and amino acid content by the
£uorescamine assay [30]. An enzymatic digest of
calf lens protein (control) was run under the same
conditions. Peak fractions were pooled according to
the A330 readings. Six peaks (designated P1^6) were
obtained.
2.6. Thin-layer chromatography (TLC)
Two hundred £uorescence units of each fraction
from the P-2 column were subjected to thin-layer
chromatography on a preparative silica gel plate
(Whatman, Hillsboro, OR, 20U20 cm, 1000 Wm)
with ethanol/ammonia (7:3, v/v) as irrigant A for
peaks P1, P2 and P3; and with n-butanol/methanol/
ammonia (7:3:2, v/v/v) as irrigant B for peaks P4, P5
and P6. The £uorophores were detected by irradia-
tion with a Wood’s lamp at the long wavelength (360
nm) setting and photographed.
2.7. Incorporation of [U-14C]ascorbic acid into
calf lens proteins
One hundred mg of dialyzed WS calf lens proteins
were incubated with 200 Wmol [U-14C]ascorbic acid
(1.0 WCi/Wmol) in 10 ml of Chelex-treated 0.1 M
phosphate bu¡er (pH 7.0) containing 1.0 mM
DTPA as described in Section 2.3. After a 2-week
incubation, the sample was extensively dialyzed
against 5.0 mM Chelex-treated phosphate bu¡er
(pH 7.0), digested, concentrated and then subjected
to a smaller Bio-Gel P-2 column (2.5U87 cm, bed
volume 430 ml) with 25 mM formic acid as eluant.
Fractions of 4.2 ml each were collected and a portion
of each fraction was measured for absorbance at 330
nm, £uorescence at 350/450 nm and radioactivity by
liquid scintillation spectrometry using a Packard
model 2100 instrument. Aliquots from each peak
were spotted on TLC plates, developed with irrigant
A and the pattern of radioactivity in each lane de-
termined with an AMBIS imaging system.
2.8. High-performance liquid chromatography
Fractions P2, P3 and P6 were isolated from the
Bio-Gel P-2 column and injected onto a preparative
C18 reversed phase preparative column (Prodigy
21.2U250 mm, Phenomenex, Torrance, CA) using
an SSI HPLC system (Scienti¢c System, Fisher Sci-
enti¢c, St. Louis, MO). The column was eluted for
2 min with 5% (v/v) acetonitrile in water containing
0.1% (v/v) hepta£uorobutyric acid (HFBA) at a
£ow rate of 10 ml/min, and then with a linear gra-
dient from 5% to 45% (v/v) acetonitrile in 0.1%
HFBA over 40 min, followed by a linear increase
to 100% acetonitrile over the next 5 min. The eluant
from the column was monitored with an on-line £uo-
rescence detector at 450 nm (excitation at 350 nm)
and a dual-wavelength absorption detector set at 280
nm and 330 nm.
Fractions P4 and P5 were similarly isolated from
the Bio-Gel P-2 column and further fractionated on
a semi-preparative reversed-phase Prodigy column
(10U250 mm) with the same solvents. The column
was eluted for 2 min with 5% acetonitrile in water
and 0.1% hepta£uorobutyric acid (HFBA) at a £ow
rate of 1.8 ml/min, and then with a linear gradient
from 5% to 25% acetonitrile in 0.1% HFBA over 20
min. The column was eluted isocratically with 25%
acetonitrile in 0.1% HFBA, for 15 min, followed by a
linear increase to 100% acetonitrile over the next 20
min. The eluant from the column was monitored
with an on-line £uorescence detector at 450 nm (ex-
citation at 350 nm) and a dual-wavelength absorp-
tion detector at 280 nm and 330 nm.
Table 1
Total yellow color (A330) of several lens protein preparations
following proteolytic digestion
Preparation n A330/g protein
Indian cataract WISS (type I and II) 5 130 þ 13
Aged human lens WISS 4 90 þ 20
4-Week ascorbate-modi¢ed CLP 3 250 þ 66
4-Week incubated CLP w/o ascorbate 3 24 þ 13
Enzymes alonea 1 11
aEnzymes equivalent to those used to digest 100 mg protein
were added in sequence to bu¡er alone and the ¢nal A330 multi-
plied by 10.
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3. Results
3.1. Lens protein digests
The washed WI fraction from Indian cataracts and
from aged normal eye bank lenses was solubilized by
sonication in water and digested with a battery of
proteolytic enzymes. An aliquot of each digest was
taken to determine the total yellow color present in
these fractions. These data are expressed as the ab-
sorbance at 330 nm/g of lens protein and shown in
Table 1. Approximately 2 g of protein was proteo-
lyzed in each preparation. The Indian cataracts (type
I and II) were a mixture of dark yellow and tan-
colored lenses, and these preparations contained
44% more A330-absorbing compounds than the
aged normal lenses. Calf lens proteins ascorbylated
for 4 weeks under air gave variable results, but the
A330 absorbance/g protein was almost twice as high
as that for the Indian cataract proteins. Similar in-
cubations in the absence of ascorbic acid did exhibit
some yellow color, but was only 10% of the prepa-
rations with ascorbic acid. Most of this color devel-
opment occurred during the concentration step after
the digestion was complete. Blank digestions with no
lens proteins were also carried out, but very little
A330 was contributed by the enzymes alone.
Samples of the digest were submitted for amino
acid analysis directly after precipitating any remain-
ing proteins or large peptides with 12% sulfosalicylic
acid. A similar aliquot was hydrolyzed with 6.0 N
HCl to determine the total amino acid content of
each preparation. These data, when corrected for
the values obtained with enzymes alone showed
that the proteolytic procedure hydrolyzed the pro-
teins at least 90% to the level of free amino acids.
3.2. Bio-Gel P-2 chromatography of the lens protein
digests
Fig. 1 shows the Bio-Gel P-2 elution pro¢le of the
proteolytic digest of a water-insoluble sonicate super-
natant fraction from Indian cataract (Fig. 1A), and
for comparison, a digest of calf lens proteins modi-
¢ed for 4 weeks with ascorbic acid (Fig. 1B). The
elution pro¢les for the absorbance at 330 nm, the
£uorescence at 350 nm excitation/450 nm emission
and the amino groups by the £uorescamine assay
are labeled in each panel. The numbers shown above
the peaks identify those peaks, which were pooled
based upon 330 nm absorbance. A similar elution
pro¢le was seen for both preparations in the early
part of the chromatogram. Later peaks were less dis-
tinct at 330 nm, but the cataract digest contained a
major late-eluting £uorescence peak, which was not
present in the ascorbate-modi¢ed proteins. The £uo-
rescence pro¢le showed a sharp peak between peaks
2 and 3. When similar fractions were diluted 10-fold,
however, a broader peak of £uorescence was seen.
Apparently the high level of absorbance at 350 nm
in peaks 2 and 3 diminished the light able to excite
the £uorophores by a ¢ltering e¡ect on both sides of
the £uorescent peak.
Peak 1 contained all of the material eluting before
the ¢rst major peak. This peak is likely composed of
mainly incompletely-digested peptides due to their
Fig. 1. Bio-Gel P-2 elution pro¢les of the proteolytic digest of
a water-insoluble sonicate supernatant (WISS) fraction from In-
dian cataract (A) and a 4-week ascorbic acid modi¢ed calf lens
protein preparation (B). The pro¢les for absorbance at 330 nm,
350/450 nm £uorescence and amino groups by the £uoresc-
amine assay [30] are labeled in each panel. The numbers shown
identify the peaks which were pooled based upon 330 nm ab-
sorbance.
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elution position, and because amino acid analysis of
this peak showed only 14% free amino acids. Peak 2
eluted slightly ahead of the main amino acid peak. It
could contain dipeptides or crosslinks, but only 40%
of the peak was present as free amino acids. Peak 3
co-eluted with the amino acid peak, while peaks 4
(fractions 72^85), 5 (fractions 86^91) and peak 6
(fractions 92^100) likely represented hydrophobically
modi¢ed amino acids, which bound to the column
matrix during elution. Amino acid analysis of all of
these peaks gave values of greater than 80% free
amino acids. Amino acid analysis also showed that
the hydrophobic amino acids Phe, Tyr and Trp
eluted in fractions 78^84, 93^97 and 110^114, respec-
tively.
3.3. TLC separation of the £uorophores present in the
fractions from the Bio-Gel P-2 column
The peaks showed in Fig. 1 were pooled, concen-
trated and the aliquots equivalent to 200 units of
£uorescence (350/450 nm) were subjected to prepara-
tive TLC separation. Fig. 2A shows a comparison of
the £uorophores present in peaks 1, 2 and 3. Ali-
quots were spotted side by side and the plate was
developed with irrigant A. Fig. 2B shows the prepa-
rative TLC separation of peaks 4, 5 and 6. In this
case the plate was developed with irrigant B. The
£uorophores were detected by irradiation with a
Wood’s lamp at the long wavelength (360 nm) setting
and photographed. The £uorophores in all six peaks
were almost identical for the Indian cataract and the
4-week ascorbic acid modi¢ed proteins. As expected,
peak 1 contained a smear of £uorescence throughout
the lane with only one prominent band. Peaks 2, 3
and 4 gave complex patterns with the majority of the
peaks co-migrating. Peak 5 had only one major £uo-
rescent band, and peak 6 contained no obviously
similar £uorophores. The faster-moving bands at
the top of the plate with peak 6 from the cataract
preparation are likely responsible for the higher £uo-
rescence seen only in the cataract digests. By and
large, however, ascorbate glycation appears to pro-
duce the same £uorophores as those seen in the cat-
aract digest. Similar results were seen for ¢ve di¡er-
ent cataract digests and three di¡erent digests of
ascorbylated lens proteins. Similar bands were also
present in the aged normal lens digests (data not
shown).
3.4. Incorporation of [U-14C]ascorbic acid into
lens proteins
The data in Figs. 1 and 2 argue that ascorbate
glycation produces modi¢ed amino acids, which are
very similar to those present in cataract WI proteins.
Fig. 2. TLC comparison of the £uorophores present in peaks P1^P6 isolated by Bio-Gel P-2 chromatography. Aliquots equivalent to
200 units of £uorescence (350/450 nm) were subjected to preparative TLC separation. (A) Comparison of the £uorophores present in
peaks P1, P2 and P3. Aliquots were spotted side by side and the plate was developed with irrigant A. (B) Preparative TLC separation
of peaks P4, P5 and P6 with irrigant B. The £uorophores were detected by irradiation with a Wood’s lamp at the long wavelength
setting.
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Fig. 3. Incorporation of [U-14C]ascorbic acid to calf lens protein. The incorporation reaction was carried out as described in detail in
Section 2. Digested protein was subjected to a small Bio-Gel P-2 gel ¢ltration chromatography (2.5U87 cm). (A,B) Pro¢les of the pro-
teins incubated with and without ascorbic acid. The pro¢les for absorbance at 330 nm absorbance, 350/450 £uorescence and radioac-
tivity (DPM) are labeled.
Fig. 4. The TLC pro¢les of labeled peaks isolated from [U-14C]ascorbic acid-modi¢ed calf lens protein obtained from the Bio-Gel P-2
chromatography shown in Fig. 3A. Peaks 2^7 were spotted on a preparative TLC plate and developed with irrigant A. The £uores-
cence in each lane was detected by irradiation with a Wood’s lamp at 360 nm and the pattern of radioactivity was determined by
scanning the plate with an AMBIS imaging system.
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However, it remained possible that the length of the
glycation reaction and the digestion could have led
to a direct modi¢cation or oxidation of the Trp res-
idues in the protein. This could lead to the formation
of yellow £uorophores by mechanisms other than the
formation of AGEs on lysine residues in the protein.
To determine whether ascorbic acid incorporation is
responsible for the yellow £uorophores, calf lens pro-
teins (10 mg/ml) were incubated with 20 mM [U-14C]-
ascorbic acid for 2 weeks, digested and subjected
to a Bio-Gel P-2 gel ¢ltration chromatography. Ra-
dioactivity measurements after dialysis gave a value
of 0.03 WCi incorporated per mg protein. This prep-
aration was compared to lens proteins incubated for
2 weeks in the absence of ascorbic acid. Fig. 3 shows
the pro¢les of the proteins incubated with (Fig. 3A)
and without (Fig. 3B) [U-14C]ascorbic acid. The 330
nm absorbance, 350/450 £uorescence and radioactiv-
ity of each fraction (4.2 ml/fraction) were measured,
and plotted. The smaller column did not resolve
peaks 2 and 3, but otherwise the pro¢le of the la-
beled digest was similar to that in Fig. 1. The major
£uorophores eluted as an early peak at tube 55, a
peak which co-eluted with the major amino acid
peak at tube 72 and several smaller peaks later in
the chromatogram. The incorporated radioactivity
was largely present in peak 3, and mirrored the
A330 pro¢le. The control digest without ascorbic
acid displayed some yellow color after concentration,
but no major peaks were seen. The digest of the
control sample of calf lens protein incubated without
[U-14C]ascorbic acid was fractionated immediately
after the [U-14C]ascorbic acid modi¢ed sample on
the same column. Fig. 3B shows that no radioactivity
remained on the column to contaminate the next run,
and little or no A330 or £uorescence was present in
the control proteins. A 3-fold increase in A280 was
seen following glycation, which eluted with peak 3
(data not shown). Since all of the hydrophobic ami-
no acids eluted later from the column, the absor-
bance in peak 3 was likely also due to the AGEs
formed.
To con¢rm that the £uorophores formed were due
to ascorbate modi¢cation, each peak from Fig. 3A
Fig. 5. Reversed-phase HPLC pro¢les for peaks P2 and P3 from the Bio-Gel P-2 column shown in Fig. 1. Peaks P2 and P3 from
both Indian cataract (A,C) and ascorbic acid modi¢ed calf lens protein (B,D) are shown. The 280 and 330 nm absorption, as well as
£uorescence at 350/450 nm, were monitored and labeled in each panel.
BBADIS 62039 13-7-01
R. Cheng et al. / Biochimica et Biophysica Acta 1537 (2001) 14^26 21
was pooled, concentrated and spotted on a prepara-
tive TLC plate (Fig. 4). Following development with
irrigant A, the £uorescent bands were located by
long wavelength illumination and photographed.
The TLC plate was then scanned to locate the radio-
active bands. While the separation of some samples
was less than that seen in Fig. 2, it is clear that al-
most all of the £uorescent bands contained radioac-
tivity. We conclude that most of the £uorophores,
especially those in peak 3, were derived from the
incorporation of ascorbic acid during the glycation
reaction.
3.5. Reversed-phase HPLC pro¢les of peaks P2
and P3
The fractions isolated from the Bio-Gel P-2 col-
umn were subjected to further puri¢cation by C-18
reversed phase HPLC. Fig. 5 shows the HPLC pro-
¢les for peaks, P2 and P3 from both Indian cataract
(Fig. 5A,C) and ascorbic acid modi¢ed calf lens pro-
tein Fig. 5B,D). The absorbance pro¢les at 280 nm
and 330 nm, as well as £uorescence at 350/450 nm,
were monitored. As shown in Fig. 5A,B, the two
main A330 and £uorophore peaks, which eluted
around 30 min (2-1 and 2-2), were identical for the
Indian cataract and the 4-week ascorbic acid modi-
¢ed proteins. A doublet A280-absorbing peak at 28
min was also present in both pro¢les. Peaks 2-1 and
2-2 both exhibited 350 nm/450 nm £uorescence, but
there were several £uorescent peaks that eluted after
the main A330 peaks in both digests, with the peaks
being slightly more prominent in the Indian cataract
sample.
Similarly, peak P3 separated into a cluster of ¢ve
prominent A330 peaks as shown in Fig. 5C (3-1 to 3-
5), which had very similar counterparts in the pro¢le
of peak P3 from the ascorbate-modi¢ed lens proteins
(Fig. 5D). Two signi¢cant A330 peaks eluted early in
the Indian cataract pro¢le, however, which had no
apparent counterpart the ascorbylated sample. The
A280 peak marked by an asterisk was absent in
Fig. 6. Reversed-phase HPLC pro¢les for peaks P4 and P5. Peaks P4 and P5 from both Indian cataract and ascorbic acid modi¢ed
calf lens protein were further fractionated by semi-preparative RP-HPLC. The 330 nm absorption (A,C) and the £uorescence at 350/
450 nm (B,D) for both Indian cataract and ascorbic acid modi¢ed calf lens proteins were monitored and are directly compared in
each panel.
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peak 3 from the ascorbylated protein digest. For the
most part, however, the £uorescence co-eluted with
the A330 pro¢le. The scale on the £uorescence read-
ings was greatly diminished to make the pro¢le visi-
ble below the others. Samples of P2 and P3 from
aged normal human lenses gave very similar pro¢les
to those in Fig. 5 (data not shown).
3.6. Reversed-phase HPLC pro¢les of peaks P4,
P5 and 6
The later-eluting peaks were also pooled and sub-
jected to RP-HPLC separation. The A330 and £uo-
rescence pro¢les are directly compared in each panel
and are shown for peaks 4 and 5 in Fig. 6 and for
peak 6 in Fig. 7. The A280 pro¢les were determined,
but not shown because they were dominated by the
absorbance of the aromatic amino acids which elute
in this area of the P-2 chromatogram. The A330 pro-
¢le in Fig. 6A shows several minor peaks eluting
between 20 and 30 min, which are similar to peaks
in the Fig. 6B, but in lesser quantity. The major peak
at 33 min was present in both digests. The £uoro-
phores in peak P4 (shown in Fig. 6B) eluted later
than the A330 peaks, but appear to be almost identi-
cal in both digests. Peak P5 (Fig. 6C) showed numer-
ous peaks at 330 nm in the cataract sample, a few of
which (5-1, 5-2 and 5-3) may also be present in the
ascorbylated protein digest. Peak 5-4, while promi-
nent in the ascorbate-modi¢ed CLP digest, was ab-
sent in the cataract digest. Fluorescent peaks 5-4 and
5-5 were present in both digests as shown in Fig. 6D.
Again, the £uorescence did not correspond exactly to
a signi¢cant A330 peak in Fig. 6C. Peak 6 from the
cataract digest contained numerous small A330 peaks
(Fig. 7). No peak could be clearly ascribed to a com-
panion peak in the ascorbate-modi¢ed protein digest.
A signi¢cant £uorescence peak was present in the
cataract digest (6-1), which appears to be similar to
a small peak in the digest of the ascorbate-modi¢ed
proteins. Clearly, there were numerous A330 peaks in
peaks P-4 and P-5 from the cataract digest that were
not present in the ascorbate-glycated digest.
4. Discussion
Aging in the human lens is characterized by the
accumulation of protein-bound yellow chromophores
and £uorophores, associated with an increase in pro-
tein aggregation and protein crosslinking. The signif-
icant challenge remains, however, to determine the
nature of these protein modi¢cations, the mecha-
nisms that give rise to these modi¢cations, and the
relationship between the browning reactions and the
extensive protein crosslinking seen in age-onset cata-
racts. The browning products are capable of absorb-
ing UVA light and producing reactive oxygen species
(ROS), which may be the cause of the mixed disul-
¢des and disul¢de crosslinks universally seen in age-
onset cataracts [31,32] and the low levels of hydroxy-
lated amino acids in brunescent cataracts [33]. Sev-
eral of these chromophores have been isolated, and
their structures determined. These represent two
types of compounds, either Trp oxidation products
[22,34,35] or advanced glycation endproducts [17^
21].
Prior results from our laboratory have argued for
Fig. 7. Reversed-phase HPLC pro¢le for peak P6. Peak P6
from both Indian cataract and ascorbic acid modi¢ed calf lens
protein were further fractionated by preparative RP-HPLC. The
330 nm absorption (A) and £uorescence at 350/450 nm (B) for
both Indian cataract and ascorbic acid-modi¢ed calf lens pro-
teins are directly compared in each panel.
BBADIS 62039 13-7-01
R. Cheng et al. / Biochimica et Biophysica Acta 1537 (2001) 14^26 23
a major role for ascorbic acid oxidation products in
AGE formation in vivo. Ascorbic acid, in vitro, glyc-
ated lens proteins 9-fold, and crosslinked proteins 90-
fold more rapidly than either glucose or fructose [26].
Lens proteins incubated with ascorbic acid for
4 weeks exhibited the same absorption and £uores-
cence spectra as the proteins present in a human
lens WI fraction [36]. Ascorbylation also caused the
formation of protein-bound sensitizers, which gener-
ate the same levels of reactive oxygen species (ROS)
in response to UVA light as aged human lens water-
insoluble proteins [37,38]. These observations en-
couraged us to investigate the breadth of the link
between ascorbic acid-induced advanced glycation
endproducts (AGEs) and the chromophores and £u-
orophores present in cataract lens proteins by gath-
ering chromatographic information on compounds
isolated from both sources. The data presented here
provide evidence to support the view that the bulk of
the yellow chromophores in human cataracts do arise
by ascorbate glycation.
Since AGEs are widely thought to be acid labile,
and because acid hydrolysis produces a myriad of
yellow £uorescent Trp degradation products, we
chose to use the enzymatic hydrolysis method of Lu-
thra et al., [23] to release the modi¢ed amino acids
from the lens proteins. Several enzymes were added
to the procedure to increase the degradation of small
peptides. The added enzymes increased the overall
proteolysis by only 5^10%, but increased the number
of modi¢ed amino acids liberated signi¢cantly and
allowed fractionation of the digests into discrete
peaks on the Bio-Gel P2 column. This procedure
resulted in 75% release of free amino acids overall,
but when corrected for the contribution of the en-
zymes, an 85% release of amino acids from the di-
gested proteins was obtained. Further, an increase of
8% was seen by acid hydrolysis due to the conversion
of Asn and Gln to Asp and Glu. Therefore, a 93%
proteolysis to free amino acids was obtained for both
the cataract and ascorbylated proteins. Oxidative
degradation of constitutive amino acids was kept to
a minimum by the presence of ascorbic acid through-
out the glycation reactions, and by carrying out the
proteolytic digestions under argon and in the dark at
all times. Bio-Gel P-2 chromatography was chosen as
the initial step to remove undigested peptides, and
because it allowed the processing of gram amounts
of digest on a single column. Yellow absorbance was
monitored at 330 nm because it was the highest non-
Trp absorbance present, and because prior work had
shown that UVA light created the greatest damage at
this wavelength [13]. Fluorescence was measured at
350 nm excitation and 450 nm emission, as these
wavelengths spanned the several £uorophores re-
ported for aged human lens proteins in the literature
[1^4] and because these were the £uorescence maxi-
ma of both the human WISS fraction and lens pro-
teins ascorbylated in vitro [37].
The fractionation of the lens protein digests by P-2
chromatography shown in Fig. 1 resolved the lens
yellow chromophores into six A330-absorbing peaks.
The bulk of the absorbance, however, was present in
two main peaks eluting either slightly before (peak 2)
or coincident with the free amino acid peak (peak 3).
Little or no di¡erence was seen between the cataract
and ascorbylated proteins, except for a large £uores-
cent peak (peak 6), which was only present in the
cataract protein digest. Side-by-side TLC separation
of the £uorophores present in each Bio-Gel P-2 peak,
showed a remarkable similarity between the two
preparations, except that the cataract proteins had
a higher overall £uorescence than the ascorbic acid-
modi¢ed proteins, while the ascorbylated proteins
had a 2-fold higher absorbance at 330 nm. The P-2
pro¢le shown is typical of the ¢ve di¡erent prepara-
tions of cataract water-insoluble (WI) proteins, and
the ascorbic acid modi¢ed pro¢le is representative of
three di¡erent preparations. Aged human lens pro-
teins gave similar results to the cataract digest
shown. When dehydroascorbic acid was substituted
for ascorbate, and the glycation reactions carried out
for 2 weeks in the absence of oxygen, a similar pro-
¢le was seen (data not shown). Further, the P-2 col-
umn was eluted under acidic conditions to prevent
further reaction of any AGE products, and all peaks
were stored in concentrated form under argon in the
cold.
The lens proteins glycated with [U-14C]ascorbic
acid showed extensive incorporation of radioactivity,
whereas previous incubations with [1-14C]ascorbate
gave little or no incorporation, as carbon 1 is readily
lost during oxidative degradation [15]. Recent in vi-
tro evidence argues that the true glycating species is
L-erythrulose [39], which along with oxalic acid are
the only degradation products of ascorbate under the
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reducing conditions which exist in the lens. P-2 chro-
matography of the ascorbylated proteins after exten-
sive dialysis and digestion demonstrated that the as-
corbate was incorporated into the protein and co-
eluted with the A330 absorbing peaks. Furthermore,
the £uorophores displayed by TLC were labeled
when scanned for radioactivity. These data argue
that the yellow chromophores arose by ascorbate in-
corporation, as opposed to oxidation of amino acids
present in the proteins. Controls where ascorbate was
omitted showed little or no absorbance peaks.
To allow greater discrimination of the A330-ab-
sorbing chromophores in the peaks eluted from the
P-2 column, each peak was further separated by RP-
HPLC. The Prodigy HPLC pro¢les in Fig. 5 showed
that the major A330 peaks present in peak 2 and peak
3 from the Indian cataract eluted at the same reten-
tion times as those from the 4-week ascorbic acid
modi¢ed calf lens proteins. All of these peaks also
exhibited absorbance at 280 nm, which is likely due
to the AGEs, as calf lens proteins incubated without
ascorbate exhibited 3-fold less A280 in either peak 2
or 3 from the P-2 column. Peaks P4-P6 also exhib-
ited common major peaks, however, a wide array of
minor peaks did not obviously correspond. These
data argue that the ascorbic acid glycation may be
a signi¢cant source of some, but not all, of the yel-
low chromophores and £uorophores present in aging
human lenses and in early brunescent cataracts.
Recently, considerable evidence has been pub-
lished supporting the binding of ¢lter compounds
(e.g., 3-hydroxykynurenine glycoside) to lens proteins
as having a major role in the formation of the chro-
mophores and £uorophores present in aged human
lenses and cataracts [24,40,41]. While these peaks are
surely present in our chromatograms, they were not
the major compounds produced by our sample work-
up. The propensity of these adducts to dissociate at
neutral or slightly basic conditions [41] may mean
that they would not have survived our digestion pro-
cedure, which includes an incubation at pH 8.5 for
24 h. Also, ¢lter compound adducts, when excited at
380 nm, exhibited emission peaks at roughly 440, 480
and 530 nm [41], but little or no 350/450 £uores-
cence. Therefore these adducts may not have been
detected, or were greatly diminished in our pro¢les.
A major 350/450 £uorescent peak does exist in aged
human lenses, and the 330^350 nm range is the ma-
jor absorbing region shown by Gaillard et al. [42] in
sections of aged human lens. The evidence presented
here argues that these chromophores and £uoro-
phores likely arise by ascorbic acid glycation. It
must be pointed out, however, that we do not
know whether other reactive sugars could produce
the same display of AGE peaks. The low reactivity
of glucose and fructose, however, argue that these
sugars are not signi¢cant contributors to the AGEs
in the lens [26,43].
These results represent only an initial step in the
isolation and puri¢cation of the yellow chromo-
phores and £uorophores present in either the cata-
ract WISS proteins or the 4-week ascorbic acid modi-
¢ed proteins; however, neither mixture had been
successfully fractionated before. Hopefully this
work can provide general methods, which can be
employed in the future, to isolate individual modi¢ed
amino acids in su⁄cient quantities from both sources
to allow proof of structural identity. Also, this meth-
odology can be employed to see how these chromo-
phore peaks develop with aging in vivo and during
glycation reactions in vitro. This represents the ¢rst
work showing an extensive chromatographic com-
parison between AGEs present in aged and patho-
logical tissue with AGEs produced by ascorbic acid
glycation in vitro.
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